U.S. Life Sciences Stock News

Buenaventura (NYSE:BVN) has approved a higher dividend payout policy, supported by strong operating cash flow. The Board also cleared a higher dividend distribution to shareholders under the new framework. The San Gabriel project is approaching completion, with ramp up reported as close to finished. For you as an investor, the combination of a higher dividend payout policy and a near complete San Gabriel ramp up is a key development for Compañía de Minas Buenaventura, a precious metals...

If you are wondering whether OGE Energy is still fairly priced after its recent run, or if the current share price is giving you a margin of safety, this article walks through what the numbers say about value. With the stock at US$49.14 and returns of 3.8% over 7 days, 12.5% over 30 days, 14.6% year to date, 10.3% over 1 year, 56.3% over 3 years and 93.0% over 5 years, many investors are asking whether the current price still makes sense. Recent attention on OGE Energy has focused on how a...

If you are wondering whether LegalZoom.com’s current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value. The stock last closed at US$7.03, with a 7 day return of 7.2%, but declines of 20.9% over 30 days, 26.7% year to date, and 30.8% over the past year. These moves have put valuation questions front and center for many investors, who are weighing short term swings against the longer term picture. Evergreen coverage like this aims...

PTC Therapeutics (PTCT) shares are in focus after the company released fourth quarter and full year 2025 results, which combined weaker quarterly figures with a sharp full year swing to positive earnings. See our latest analysis for PTC Therapeutics. At a share price of US$68.19, PTC Therapeutics has recently seen weaker short term share price returns, with a 30 day share price return of 9.72% and a year to date share price return of 11.14%. Its 1 year total shareholder return of 23.4% and 3...

Fulton Financial (FULT) is back on investor radars after a recent share pullback, with the stock closing at US$20.45. That is shifting sentiment toward its valuation and the bank’s underlying financial profile. See our latest analysis for Fulton Financial. The recent 5.5% one day share price decline and 8.7% 7 day share price return dip sit against a 90 day share price return of 11.2% and 1 year total shareholder return of 7.3%. This suggests that longer term momentum is still intact despite...

In recent months, BankUnited reported solid quarterly results and continued investments in digital capabilities and new markets, even as its net interest income growth trailed the broader banking industry and analysts projected a weaker efficiency ratio ahead. This tension between operational expansion and concerns about slowing profitability has led some analysts to question how durable BankUnited’s current growth ambitions may be. Next, we’ll examine how these concerns about slowing net...

Amneal Pharmaceuticals (NasdaqGS:AMRX) reported strong Q4 2025 results, highlighting progress across specialty, injectables, biosimilars, and complex generics. The company announced multiple product launches and regulatory approvals, expanding its presence in higher value segments. Management highlighted a promising pipeline, including biosimilars expected to enter the US market. Amneal also emphasized its collaboration with Pfizer on GLP-1 therapies as a key focus area for future...

Caris Life Sciences (NasdaqGS:CAI) reported an interim readout from its Achieve 1 study for the Caris Detect multi cancer early detection blood test. The interim data show sensitivity and specificity that the company says outperform current methylation based approaches. Caris is adding Whole Transcriptome Sequencing to Caris Detect to deepen molecular resolution in the test. The company also introduced a new AI powered breast cancer signature in its Molecular Tumor Board Report to expand...

Oncolytics Biotech (NasdaqCM:ONCY) has completed patient enrollment in its Phase 1/2 GOBLET study. The company is moving ahead with pivotal trials in squamous cell anal cancer and metastatic colorectal cancer. Management is shifting clinical focus and resources toward these rare cancer indications and planning FDA interactions related to potential approval pathways. Oncolytics Biotech focuses on cancer therapies, and the GOBLET study sits at the center of that effort. With enrollment now...

Daktronics (NasdaqGS:DAKT) has agreed to supply an integrated digital display system across the OCVIBE campus, a large mixed-use development project. The company also announced an executive leadership change, with the former Interim President and CEO moving into an advisory role. Both updates relate to Daktronics' positioning in large commercial installations and its ongoing leadership structure. Daktronics focuses on electronic scoreboards, digital signage, and large-format LED video...

Reliance, Inc. (NYSE:RS) raised its quarterly dividend. The company is continuing its long term share buyback program. Both actions reflect management’s current approach to capital allocation and shareholder distributions. Reliance, Inc. (NYSE:RS) operates in the metals service center space, supplying processed metal products to a wide range of end markets. In that kind of business, decisions around dividends and buybacks can matter as much to investors as day to day price moves for steel...

VEON and ride hailing operator Hala have signed a Memorandum of Understanding to expand mobility services in frontier markets. The partnership aims to combine Hala's ride hailing capabilities with VEON's digital platforms and local presence. The agreement builds on VEON's existing mobility offerings and Hala's scale in Dubai to broaden VEON's digital ecosystem beyond telecom. NasdaqGS:VEON currently trades at $55.89, with a return of 24.9% over the past year and a very large gain over three...

Richtech Robotics: Context for Recent Stock Performance Richtech Robotics (RR) has drawn attention after a recent stretch of weak trading, with the stock showing negative returns over the past week, month, and past 3 months. That price action has investors rechecking the story behind this US robotics player. See our latest analysis for Richtech Robotics. At a share price of $2.49, Richtech Robotics has seen momentum fade recently, with a 1 month share price return of 30.45% and a year to date...

Ginkgo Bioworks Holdings (DNA) is back in focus after reporting 2025 results that combined smaller losses and lower cash burn with a clear pivot toward robotics-powered autonomous labs and a planned biosecurity divestiture. See our latest analysis for Ginkgo Bioworks Holdings. The earnings release, biosecurity divestiture plan, and new autonomous lab contracts have coincided with heavy selling, including a 30.48% 1-day share price return decline and a 26.79% 7-day share price return decline...

In February 2026, Sidus Space, Inc. filed for a US$100 million at-the-market follow-on offering of its Class A common stock, enabling share sales on Nasdaq and other permitted venues with ThinkEquity as sales agent. This flexible at-the-market structure allows Sidus Space to time equity raises as needed, while introducing potential dilution considerations for existing shareholders. We’ll now examine how this flexible at-the-market equity program with ThinkEquity shapes Sidus Space’s...

PicS stock moves after recent performance shifts PicS (PICS) has drawn fresh attention after recent trading saw a 3.8% one day decline and an 8.7% gain over the past week, compared with weaker performance over the past month and year to date. See our latest analysis for PicS. With the share price at $17.08, PicS has seen a 3.8% one day share price return decline, a strong 7 day rebound, yet softer 30 day and year to date share price returns. This suggests that momentum has cooled after a...

If you are wondering whether Gen Digital is attractively priced right now, you are not alone. This article is aimed squarely at helping you make sense of the current valuation. The stock closed at US$22.57, with returns of 1.0% over the last 7 days, a 5.9% decline over 30 days, a 13.4% decline year to date, a 15.9% decline over 1 year, and gains of 24.8% over 3 years and 24.0% over 5 years. Taken together, these figures raise questions about how the market is currently judging it. Recent...

UL Solutions (NYSE:ULS) announced an 11.5% increase to its quarterly dividend. Management highlighted digitalization, energy transition, and sustainability as key areas connected to recent growth efforts. Executives discussed progress in laboratory expansion, software integration, and restructuring initiatives. UL Solutions operates in testing, inspection, certification, and related software, serving companies that need to meet safety, quality, and regulatory standards. As more products,...

Rexford Industrial Realty, Inc. recently promoted Managing Director of Operations John Nahas to Chief Operating Officer, effective April 1, 2026, completing an executive reshuffle alongside incoming CEO Laura Clark and reaffirming tighter expense guidance and lower aggregate executive compensation. The combination of a refreshed leadership team, a roughly 50% cut in total executive pay, and ongoing cost controls highlights a sharper emphasis on operational discipline and capital...

ACI Worldwide secured the first UK deployment of its Connetic cloud-native payments platform with a major UK retail bank. The rollout brings multiple UK payment schemes onto a single platform, targeting greater efficiency and modernization for the bank. This marks a key step in ACI Worldwide’s push into European digital payments with its next-generation Connetic offering. For investors tracking ACI Worldwide, ticker NasdaqGS:ACIW, the Connetic win in the UK lands at a time when the stock...

Schrödinger (SDGR) has drawn fresh attention after reporting 2025 results, with total revenue of US$255.87 million, sales of US$56.37 million, and a net loss of US$103.27 million, along with operational changes. See our latest analysis for Schrödinger. The earnings update and shift toward hosted, throughput based licensing arrived after a tough stretch for shareholders, with a 90 day share price return decline of 29.23% and a 1 year total shareholder return decline of 45.94%, suggesting...

AXIS Capital Holdings recently declared a quarterly US$0.44 common dividend and a US$34.375 Series E preferred dividend per share, both payable on April 15, 2026 to shareholders of record on March 31, 2026, while also authorizing an additional US$300,000,000 share repurchase program. Together with a board retirement, these capital return moves underline how AXIS is currently prioritizing shareholder distributions alongside its ongoing specialty insurance focus. We’ll now examine how the...

In late February 2026, Stanley Black & Decker announced it would close its last New Britain, Connecticut manufacturing plant, ending more than 180 years of local production and affecting about 300 workers as demand for single-sided tape measures structurally declines. At the same time, the Board reaffirmed a regular cash dividend of US$0.83 per share, underscoring management’s commitment to ongoing capital returns even as it reshapes its manufacturing footprint. Next, we’ll examine how...

Herc Holdings (NYSE:HRI) has completed its largest acquisition to date, expanding its equipment rental footprint across local markets. The company is now concentrating on post-merger integration, including combining operations, systems, and teams across the enlarged network. Management is prioritizing cost synergies, higher used equipment sales, and branch network changes following the closing of the deal. Herc Holdings runs a broad equipment rental business that serves construction,...